New Paper Out – Evaluation of walking activity and gait to identify physical and mental fatigue in neurodegenerative and immune disorders
A new paper by Hinchliffe et al. has been published. In this paper the authors explore the relationships between gait characteristics derived from an inertial measurement unit (IMU) and patient-reported fatigue in the IDEA-FAST feasibility study. The current knowledge of the relationships between walking and abnormal fatigue in NDDs and IMIDs is very limited. Therefore, […]
IDEA-FAST May 2024 Newsletter is Out!
We are proud to announce the latest edition of the IDEA-FAST Newsletter is here! Here are some of the highlights: Over 1200 participants recruited across 19 active sites in our Clinical Observation Study, thanks to the hard work of the IDEA-FAST members Spotlight on Young Researchers and their work in IDEA-FAST Most recent project deliverables […]
IDEA-FAST General Assembly 2024 – Desenzano del Garda
On March 12th-13th, in Desenzano del Garda, the IDEA-FAST consortium gathered to discuss current progress and next steps during the 2024 General Assembly. More than 100 participants from over 50 partner organizations took part in the sessions, in person and online, including participants in our Clinical Observational Study (COS). The assembly included sessions that enabled […]
Early Career Researcher Spotlight – Laura Kuijper
In this edition of the Early Career Researcher Spotlight we talk to Ms. Laura Kuijper. Laura Kuijper is a research psychologist at the Leiden University Medical Center (LUMC). Since graduating cum laude from her Cognitive Neuroscience masters program at Leiden University in 2021, she works at the Huntington’s Disease Research Team on multiple studies related […]
ECCO Congress – Chris Lamb Presentation
Dr. Chris Lamb of Newcastle University was a keynote speaker during the ECCO European Crohn’ and Colitis Organisation Congress held on February 21st -24th in Stockholm. His plenary talk with Cate Titterton focused on the similarities and differences between patient and clinician endpoints in therapy.
New Partners Join IDEA-FAST Consortium
We are excited to announce two new partners have officially joined the IDEA-FAST consortium. Bristol-Myers Squibb and University College Cork have commenced their activities in the project during the last quarter of 2023. Bristol-Myers Squibb (BMS) is a global pharma company with the mission to discover, develop and deliver innovative medicines for an array of […]
Project Milestone – 1000 Clinical Observation Study Participants
We’re thrilled to share a significant milestone in our journey – the recruitment of the 1000th participant in our IDEA-FAST Clinical Observation Study (COS)! This marks a monumental achievement as we hit four digits for the first time and reach halfway to our ambitious target of 2000 participants. Achieving this milestone is a reflection of […]
Associacion Parkinson Madrid Conference – Participation of Patients with Parkinsons’ Disease in Clinical Trials
In attention to our Spanish speaking community! Our partners from Asociación Parkinson Madrid are organising on Friday, 26 January, a conference about the participation of patients with Parkinsons’ disease in clinical trials. The sessions will also have active participation from our IDEA-FAST participants from the Clinical Observational Study. Find out more at: emp.onl/s3CWO
IDEA-FAST Highlighted as an Excellent Innovation by Innovation Radar
We are proud to announce that IDEA-FAST has been highlighted in the European Commission Innovation Radar. Three of our Innovations have been evaluated as excellent by the European Commission. Our main innovations encompass: New digital biomarkers for clinical trials in neurodegeneration and immune-inflammatory disorders Digital multi source dataset-biobank for the development of digital biomarkers Data […]
The Ignored Symptom: Sleep Dysfunction in Neurodegenerative Diseases
Tonight nearly 750 million people in Europe will put on their pajamas, lay in their beds, close their eyes and try to fall into a deep and restful sleep. However, 35% of these people will lay awake, toss and turn and have disrupted and unsatisfying sleep. The morning after a restless night is usually met […]
